Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We use our state-of-the-art dedicated workflow for designing focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
P26022
UPID:
PTX3_HUMAN
Alternative names:
Pentaxin-related protein PTX3; Tumor necrosis factor alpha-induced protein 5; Tumor necrosis factor-inducible gene 14 protein
Alternative UPACC:
P26022; B2R6T6; Q38M82
Background:
Pentraxin-related protein PTX3, also known as Tumor necrosis factor alpha-induced protein 5 and Tumor necrosis factor-inducible gene 14 protein, plays a crucial role in innate immunity. It is involved in pathogen resistance, inflammatory responses, self-component clearance, and female fertility.
Therapeutic significance:
Understanding the role of Pentraxin-related protein PTX3 could open doors to potential therapeutic strategies.